InflaRx (IFRX) Non-Current Deferred Tax Liability (2019 - 2026)

InflaRx's (IFRX) quarterly Non-Current Deferred Tax Liability came in at $669358.6 in Q1 2026, up 56.28% year-on-year from $428310.5 in Q1 2025, and down 10.29% quarter-over-quarter from $746120.5 in Q4 2025.

InflaRx (IFRX) Non-Current Deferred Tax Liability (2019 - 2026) Analysis & Trends

InflaRx has disclosed Non-Current Deferred Tax Liability across 8 years of filings, most recently posting $669358.6 for Q1 2026.

  • Non-Current Deferred Tax Liability for Q1 2026 came in at $669358.6, up 56.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $669358.6 (up 56.28% YoY), and the FY2025 annual result was $746120.5, up 71.97% from the prior year.
  • Non-Current Deferred Tax Liability came in at $669358.6 for Q1 2026 at InflaRx, down from $746120.5 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.2 million in Q2 2022 to a low of $428310.5 in Q1 2025.
  • The 5-year median for Non-Current Deferred Tax Liability is $802345.6 (2023), against an average of $791667.8.
  • Across the five-year window, Non-Current Deferred Tax Liability surged 173.79% in 2022 and slumped 45.92% in 2024, its largest moves.
  • InflaRx's Non-Current Deferred Tax Liability stood at $1.0 million in 2022, then slipped by 20.35% to $802345.6 in 2023, then plunged by 45.92% to $433871.1 in 2024, then jumped by 71.97% to $746120.5 in 2025, then dropped by 10.29% to $669358.6 in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $669358.6 (Q1 2026), $746120.5 (Q4 2025), and $818506.9 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40

Historic Data

Download Data
DateValue
Mar 31, 2026 669,358.61
Mar 31, 2026 669,358.61
Dec 31, 2025 746,120.46
Dec 31, 2025 746,120.46
Sep 30, 2025 818,506.91
Sep 30, 2025 818,506.91
Jun 30, 2025 447,388.96
Jun 30, 2025 447,388.96
Mar 31, 2025 428,310.51
Mar 31, 2025 428,310.51
Dec 31, 2024 433,871.10
Dec 31, 2024 433,871.10
Sep 30, 2024 547,932.46
Sep 30, 2024 547,932.46
Jun 30, 2024 647,419.43
Jun 30, 2024 647,419.43
Mar 31, 2024 789,848.01
Mar 31, 2024 789,848.01
Dec 31, 2023 802,345.61
Dec 31, 2023 802,345.61